2 results match your criteria: "Department of Internal Medicine University of Toledo Toledo Ohio USA.[Affiliation]"
Article Synopsis
- - Resmetirom, a selective thyroid hormone receptor-β agonist, shows potential in treating non-alcoholic steatohepatitis (NASH), a major cause of liver-related health issues globally.
- - A systematic review and meta-analysis indicated that Resmetirom significantly reduced low-density lipoprotein cholesterol (LDL-C) and alanine aminotransferase (ALT) levels compared to a placebo, although it also increased the risk of side effects like diarrhea and nausea.
- - Overall, Resmetirom appears to be a promising option for improving liver health in NASH patients, potentially filling a gap in current treatment strategies.
Introduction: Catheter placement and stability are well-known challenges in atrial fibrillation (AF) ablation. As a result, steerable sheaths (SS) were developed to improve catheter stabilization and maintain proper catheter-tissue contact. The purpose of this systematic review and meta-analysis is to see if employing a SS influences procedure outcome.
View Article and Find Full Text PDF